Share Twitter LinkedIn Facebook Email Pascal Besman, Chief Operating Officer of PharmaMar, talks about Development in Small Cell has been Much Slower | Most Drivers in Non-Small Cell are Proliferative at Annual Meeting 2018
Lurbinectedin: Enhancing Immunotherapy Efficacy in Small Cell Lung Cancer Small Cell Lung Cancer 3 Mins Read
HARPOON THERAPEUTICS: New data on HPN328 T cell engager at ESMO 2023 Small Cell Lung Cancer 2 Mins Read
Emerging Treatment for SCLC – Leading Developments & Current Questions in Lung Cancer Small Cell Lung Cancer 1 Min Read